NIMG-26. EVALUATING THE DAYS GAINED RESPONSE METRIC IN CLINICAL TRIALS USING BEVACIZUMAB PLUS ADDITIONAL AGENTS FOR RECURRENT GLIOBLASTOMA

Determining effective therapies for patients with recurrent glioblastoma remains difficult especially in small early phase clinical trials. Currently utilized estimators of treatment response rely on two-dimensional measurements of tumor progression (e.g. RANO, RECIST, MacDonald) that have often fal...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Singleton, Kyle, Johnston, Sandra, Rickertsen, Cassandra, Keith Anderson, S, De Leon, Gustavo, Whitmire, Scott, Clark-Swanson, Kamala, Bendok, Bernard, Mrugala, Maciej, Porter, Alyx, Galanis, Evanthia, Swanson, Kristin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Neuro-Imaging
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847498/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.697
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items